Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: J Urol. 2020 Jan 23;204(1):63–70. doi: 10.1097/JU.0000000000000761

Table 2A.

Observed objective response rate (ORR) by tumor histology subtype

N ORR (%) OR (95% CI) vs. PUC p value
PUC 278 28%
VUC 117 29% 1.03 (0.64 - 1.66) 0.90
Squamous 50 28% 0.98 (0.50 - 1.91) 0.95
Micropapillary 25 28% 0.98 (0.39 - 2.44) 0.97
Sarcomatoid 16 38% 1.51 (0.53 – 4.30) 0.44
Plasmacytoid 12 17% 0.50 (0.11 - 2.35) 0.38
Adenocarcinoma 10 20% 0.63 (0.13 – 3.03) 0.56
NE 8 25% 0.84 (0.17 – 4.25) 0.83
OR (95% CI) vs. VUC w/o NE
VUC without NE 109 29%
NE 8 25% 0.80 (0.15 – 4.19) 0.79

NE: neuroendocrine, PUC, pure urothelial carcinoma; VUC, variant urothelial carcinoma